AIM
ZYNE

Acrospire Investment Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Acrospire Investment Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-546
Closed -$11K – 2629
2017
Q1 		$11K Buy
546
+441
+420% +$8.89K 0.01% 1851
2016
Q4 		$2K Buy
+105
New +$2K ﹤0.01% 2135